Literature DB >> 26785480

NAD⁺ in aging, metabolism, and neurodegeneration.

Eric Verdin1.   

Abstract

Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate-ribose) polymerases. Cellular NAD(+) concentrations change during aging, and modulation of NAD(+) usage or production can prolong both health span and life span. Here we review factors that regulate NAD(+) and discuss how supplementation with NAD(+) precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26785480     DOI: 10.1126/science.aac4854

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  387 in total

Review 1.  Pyridine Dinucleotides from Molecules to Man.

Authors:  Joshua P Fessel; William M Oldham
Journal:  Antioxid Redox Signal       Date:  2017-07-25       Impact factor: 8.401

2.  A functional link between NAD+ homeostasis and N-terminal protein acetylation in Saccharomyces cerevisiae.

Authors:  Trevor Croft; Christol James Theoga Raj; Michelle Salemi; Brett S Phinney; Su-Ju Lin
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

3.  Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.

Authors:  Sathish Periyasamy; Sujit John; Raman Padmavati; Preeti Rajendren; Priyadarshini Thirunavukkarasu; Jacob Gratten; Anna Vinkhuyzen; Allan McRae; Elizabeth G Holliday; Dale R Nyholt; Derek Nancarrow; Andrew Bakshi; Gibran Hemani; Deborah Nertney; Heather Smith; Cheryl Filippich; Kalpana Patel; Javed Fowdar; Duncan McLean; Srinivasan Tirupati; Arunkumar Nagasundaram; Prasad Rao Gundugurti; Krishnamurthy Selvaraj; Jayaprakash Jegadeesan; Lynn B Jorde; Naomi R Wray; Matthew A Brown; Rachel Suetani; Jean Giacomotto; Rangaswamy Thara; Bryan J Mowry
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

4.  Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice.

Authors:  Nina Klimova; Aaron Long; Tibor Kristian
Journal:  J Neurosci Res       Date:  2019-02-23       Impact factor: 4.164

5.  TIR Domain Proteins Are an Ancient Family of NAD+-Consuming Enzymes.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aldrin Kay Yuen Yim; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Curr Biol       Date:  2018-01-25       Impact factor: 10.834

6.  Role of Sirtuins in Retinal Function Under Basal Conditions.

Authors:  Jonathan B Lin; Shunsuke Kubota; Raul Mostoslavsky; Rajendra S Apte
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

7.  CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Authors:  Jeffrey P Chmielewski; Sarah C Bowlby; Frances B Wheeler; Lihong Shi; Guangchao Sui; Amanda L Davis; Timothy D Howard; Ralph B D'Agostino; Lance D Miller; S Joseph Sirintrapun; Scott D Cramer; Steven J Kridel
Journal:  Mol Cancer Res       Date:  2018-08-03       Impact factor: 5.852

8.  Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation.

Authors:  Pascal Röderer; Lara Klatt; Felix John; Verena Theis; Konstanze F Winklhofer; Carsten Theiss; Veronika Matschke
Journal:  Mol Neurobiol       Date:  2018-03-16       Impact factor: 5.590

Review 9.  NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies.

Authors:  Jonathan B Lin; Rajendra S Apte
Journal:  Prog Retin Eye Res       Date:  2018-06-12       Impact factor: 21.198

Review 10.  Nuclear DNA damage signalling to mitochondria in ageing.

Authors:  Evandro Fei Fang; Morten Scheibye-Knudsen; Katrin F Chua; Mark P Mattson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.